Evidence map›Paper›PMID 31096551›Full record

ArticleInternational journal of molecular sciences2019

A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS).

Aron B Fisher, Chandra Dodia, Shampa Chatterjee, Sheldon I Feinstein

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Protective Effects ofInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. The Role of Peroxiredoxins in the Regulation of Sepsis.Antioxidants (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. A Peptide Inhibitor of Peroxiredoxin 6 Phospholipase AAntioxidants (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aron B FisherInstitute for Environmental Medicine, Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. ABF@upenn.edu.
Chandra DodiaInstitute for Environmental Medicine, Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. cdodia@pennmedicine.upenn.edu.
Shampa ChatterjeeInstitute for Environmental Medicine, Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. shampac@pennmedicine.upenn.edu.
Sheldon I FeinsteinInstitute for Environmental Medicine, Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. sif@pennmedicine.upenn.edu.
University of Pennsylvania · US

Funding

Role of Peroxiredoxin 6 in the Repair of Peroxidized Cell MembranesR01HL102016 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FISHER, ARON B. · 2010 to 2018
$4.6M
National Heart, Lung, and Blood Institute R-01 HL-102016
6 · The paper itself

Abstract

We have previously derived three related peptides, based on a nine-amino acid sequence in human or rat/mouse surfactant protein A, that inhibit the phospholipase A

Indexed as

Acute Lung InjuryAnimalsDisease Models, AnimalEnzyme InhibitorsInjections, IntraperitonealLipopolysaccharidesLungMiceMice, Inbred C57BLNADPH Oxidase 2Oxidation-ReductionPeptidesPeroxiredoxin VIPhospholipase A2 InhibitorsPhospholipases A2Reactive Oxygen SpeciesCybb protein, mouseEnzyme InhibitorsLipopolysaccharidesNADPH Oxidase 2PeptidesPeroxiredoxin VIPhospholipase A2 InhibitorsPhospholipases A2Reactive Oxygen Speciesacute lung injuryperoxiredoxin 6PLA2 inhibitory peptide 2 (PIP-2)reactive oxygen species (ROS)sepsis

Identifiers

PMID31096551
PMCPMC6566262
OpenAlexW2945716744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.